ES2091018T3 - Procedimiento para la deteccion de enfermedades neoplasicas. - Google Patents

Procedimiento para la deteccion de enfermedades neoplasicas.

Info

Publication number
ES2091018T3
ES2091018T3 ES93916537T ES93916537T ES2091018T3 ES 2091018 T3 ES2091018 T3 ES 2091018T3 ES 93916537 T ES93916537 T ES 93916537T ES 93916537 T ES93916537 T ES 93916537T ES 2091018 T3 ES2091018 T3 ES 2091018T3
Authority
ES
Spain
Prior art keywords
detection
detect
growth factor
processes
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916537T
Other languages
English (en)
Inventor
Michael Philip Nova
Ana-Maria Gonzalez
J Andrew Baird
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whittier Institute for Diabetes and Endocrinology
Original Assignee
Whittier Institute for Diabetes and Endocrinology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whittier Institute for Diabetes and Endocrinology filed Critical Whittier Institute for Diabetes and Endocrinology
Application granted granted Critical
Publication of ES2091018T3 publication Critical patent/ES2091018T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PROCESOS PARA DETECTAR LA PRESENCIA DE ENFERMEDAD NEOPLASTICA. LOS PROCESOS COMPRENDEN LA DETECCION DE UN PRODUCTO ASOCIADO CON LA EXPRESION DE GENES QUE CODIFICAN LOS RECEPTORES DE PROTEINA PARA L FACTOR DE CRECIMIENTO DE FIBROBLASTO EN CELULAS O UN PRODUCTOS INDICATIVO DE NIVELES ELEVADOS DE UN RECEPTOR DE FACTOR DE CRECIMIENTO DE FIBROBLASTO EN UN FLUIDO CORPORAL. LA DETECCION SE PUEDE LLEVAR A CABO DE VARIAS MANERAS, INCLUIDA LA HIBRIDACION PARA DETECTAR LA PRESENCIA DE ARNM QUE CODIFICA UN RECEPTOR DE FACTOR DE CRECIMIENTO O ENSAYOS INMUNOLOGICOS PARA DETECTAR LA PRESENCIA DE PROTEINA RECEPTORA. TAMBIEN SE PREVEN KITS PARA REALIZAR LOS PROCESOS.
ES93916537T 1992-06-18 1993-06-14 Procedimiento para la deteccion de enfermedades neoplasicas. Expired - Lifetime ES2091018T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90064692A 1992-06-18 1992-06-18

Publications (1)

Publication Number Publication Date
ES2091018T3 true ES2091018T3 (es) 1996-10-16

Family

ID=25412867

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916537T Expired - Lifetime ES2091018T3 (es) 1992-06-18 1993-06-14 Procedimiento para la deteccion de enfermedades neoplasicas.

Country Status (10)

Country Link
US (1) US5670323A (es)
EP (1) EP0646182B1 (es)
AT (1) ATE141958T1 (es)
AU (1) AU686566B2 (es)
CA (1) CA2136439A1 (es)
DE (1) DE69304331T2 (es)
DK (1) DK0646182T3 (es)
ES (1) ES2091018T3 (es)
GR (1) GR3021817T3 (es)
WO (1) WO1994000599A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6446194A (en) * 1993-03-17 1994-10-11 Whittier Institute For Diabetes And Endocrinology, The Monoclonal antibodies specific for fibroblast growth factor receptors, immunotoxins, and use thereof
US6323316B1 (en) 1996-06-18 2001-11-27 The United States Of America As Represented By The Secretary Of The Department Of And Human Services Fibroblast growth factor receptor activating gene 1 and related compositions and methods
WO1999035159A1 (en) * 1998-01-08 1999-07-15 Brigham & Women's Hospital, Inc. Lymphoma/leukemia oncogene, oncoprotein and methods of use
WO2005066211A2 (en) * 2003-12-19 2005-07-21 Five Prime Therapeutics, Inc. Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
NZ590050A (en) 2008-06-04 2012-08-31 Amgen Inc Fgf21 mutants and uses thereof
WO2010042747A2 (en) 2008-10-10 2010-04-15 Amgen Inc. Fgf21 mutants and uses thereof
JO3469B1 (ar) * 2009-05-05 2020-07-05 Amgen Inc طافرات fgf21 واستخداماتها
EP2427207B1 (en) 2009-05-05 2017-08-16 Amgen, Inc Fgf21 mutants and uses thereof
WO2011130417A2 (en) 2010-04-15 2011-10-20 Amgen Inc. HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
AR123306A1 (es) 2020-08-21 2022-11-16 Genzyme Corp Anticuerpos fgfr3 y métodos de uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68921918T2 (de) * 1988-05-09 1995-09-07 Univ Temple Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
EP0387777A3 (en) * 1989-03-15 1992-01-02 Takeda Chemical Industries, Ltd. Method for detecting and measuring fgf and for diagnosis of tumor
CA2063431C (en) * 1989-07-06 2002-10-29 Lewis T. Williams Receptors for fibroblast growth factors
DE69129070T2 (de) * 1990-09-19 1998-08-20 Roger Williams General Hospita Behandlung von tumorogenen pathophysiologischen zuständen durch verwendung von f4f-cytotoxinkonjugaten

Also Published As

Publication number Publication date
DK0646182T3 (da) 1996-09-16
US5670323A (en) 1997-09-23
AU4635493A (en) 1994-01-24
EP0646182B1 (en) 1996-08-28
DE69304331D1 (de) 1996-10-02
DE69304331T2 (de) 1997-01-16
GR3021817T3 (en) 1997-02-28
WO1994000599A2 (en) 1994-01-06
AU686566B2 (en) 1998-02-12
CA2136439A1 (en) 1994-01-06
ATE141958T1 (de) 1996-09-15
WO1994000599A3 (en) 1994-02-17
EP0646182A1 (en) 1995-04-05

Similar Documents

Publication Publication Date Title
ES2091018T3 (es) Procedimiento para la deteccion de enfermedades neoplasicas.
DE69126430D1 (de) Ligand für das neu-gen-produkt
DE69019765D1 (de) Spannungsverminderndes Sicherheitsgurtsystem.
DE68922023D1 (de) Privates Funkkommunikationssystem unter Verwendung von optischen Glasfasern.
DE69111445D1 (de) Mischung für reifenlaufflächen.
ES2046462T3 (es) Marcadores de activacion de celulas "t".
DE3888712D1 (de) Detektorobjectiv für Rastermikroskope.
ES2110993T3 (es) Anticuerpos monoclonales especificos para la toxina b de clostridium difficile.
FI900403A0 (fi) Pao longitudinalt magnetband inspelande system, magnetbandanordning foer anvaendning i systemet och magnethuvud foer anvaendning i magnetbandanordningen.
ATE250201T1 (de) Licht verteilungssystem
IT7923836A0 (it) Procedimento, per la realizzazione di riflettore ottico e particolarmente per proiettore d'automobile e macchina per la sua messa in opera.
DE68906720D1 (de) Toilettensystem mit herausnehmbarem auffangtank fuer freizeitfahrzeuge.
DE59103326D1 (de) Optisches Messsystem für die menschliche Hornhaut.
NO903812D0 (no) Ekspresjonssystem fra sopp.
FI901311A7 (fi) Kvistningsanordning.
IT8741514A0 (it) Impianto automatico per la copertura di campi, particolarmente di quelli adibiti ad uso sportivo.
DE69020754D1 (de) Doppelfokusdetektor unter Ausnutzung der chromatischen Aberration.
DE69009927D1 (de) Faserverstärkter Riemen.
NO901613D0 (no) Fremgangsmaate for aa oeke foelsomheten ved luminescens-undersoekelser.
IT8321259A0 (it) Anello di stiro per fibra tessile.
FI904560A0 (fi) Farmakologiskt aktiv foerening, framstaellning och anvaendning.
AU8160991A (en) Photometer arrangement with scattered light trap
MX9604079A (es) Ensayo homogeneo de sondas genicas con un receptor dirigido contra el marcador.
ES1011761Y (es) Embudo domestico de un solo uso.
IT8983433A0 (it) Sfibratrice per fibre liberiane.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 646182

Country of ref document: ES

FG2A Definitive protection

Ref document number: 646182

Country of ref document: ES